Search
for
Sort by
Research 841–870 of 1000+
- Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: A cross-sectional study
- Acne in women
- 5α-Reductase inhibitors in androgenetic alopecia
- Green formulation of spironolactone loaded chitosan coated nano lipid carrier for treatment of acne vulgaris: a randomized double-blind clinical trial
- Effects of <i>In Utero</i> Exposure to D-004, a Lipid Extract from <i>Roystonea regia</i> Fruits, in the Male Rat: A Comparison with Finasteride
- Hair loss among transgender and gender‐nonbinary patients: a cross‐sectional study
- Post-finasteride syndrome – does it really exist?
- The great atopic diseases epidemic: does chemical exposure play a role?
- A Case of Familial Male-limited Precocious Puberty with a Novel Mutation
- New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis
- Intricate diagnosis due to falsely elevated testosterone levels by immunoassay
- Efficacy and safety of a dietary supplement containing a lipid co-extract from Serenoa repens and Pygeum africanum for the treatment of androgenetic alopecia (AGA) in women. Results of a randomized, double-blind, placebo-controlled clinical trial
- Compounding as a Current Therapeutic Option in Dermatology
- Immunohistochemical Study on the Hair Growth Promoting Effect of Yonnyuniksoogobon-dan
- Multi-specialty Physician Preferences and Perceptions in Treatment and Management of Polycystic Ovary Syndrome in China: Survey and Discrete Choice Experiment
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Management of women with hirsutism in Kosovo
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Priorities for efficacy trials of gender-affirming hormone therapy with estrogen: collaborative design and results of a community survey
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- BH03: Systemic sclerosis and frontal fibrosing alopecia: a novel combination of scarring alopecia
- Optimal concentration selection of active pharmaceutical ingredients in the cream-mask intended for androgenic alopecia treatment according to experimental results on paramecium caudatum biological model
- Polycystic ovarian syndrome
- Hair Disorders
- Postmenopausal Alopecia (Hair Loss)
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Testosterone therapy for transgender men
- Frontal fibrosing alopecia: a survey in 16 patients
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review